{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:40:22Z","timestamp":1792118422234,"version":"4.4.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T00:00:00Z","timestamp":1661817600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.ebiom.2022.104262","type":"journal-article","created":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T06:56:26Z","timestamp":1663829786000},"page":"104262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Unique and shared systemic biomarkers for emphysema in Alpha-1 Antitrypsin deficiency and chronic obstructive pulmonary disease"],"prefix":"10.1016","volume":"84","author":[{"given":"K.A.","family":"Serban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.A.","family":"Pratte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Strange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.A.","family":"Sandhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Beiko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.A.","family":"Spittle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Hamzeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.K.","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.D.","family":"Hobbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.P.","family":"Hersh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.L.","family":"DeMeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.H.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.P.","family":"Bowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"26","key":"10.1016\/j.ebiom.2022.104262_bib0001","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1056\/NEJMcp0900449","article-title":"Clinical practice. Alpha1-Antitrypsin deficiency","volume":"360","author":"Silverman","year":"2009","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.ebiom.2022.104262_bib0002","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1503\/cmaj.111749","article-title":"Alpha-1 Antitrypsin deficiency: a commonly overlooked cause of lung disease","volume":"184","author":"Brode","year":"2012","journal-title":"CMAJ"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104262_bib0003","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1183\/09031936.06.00062305","article-title":"Estimated numbers and prevalence of Pi*S and Pi*Z alleles of alpha1-antitrypsin deficiency in European countries","volume":"27","author":"Blanco","year":"2006","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104262_bib0004","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1164\/rccm.202002-0262OC","article-title":"Clarifying the risk of lung disease in SZ Alpha-1 Antitrypsin deficiency","volume":"202","author":"Franciosi","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104262_bib0005","doi-asserted-by":"crossref","first-page":"270","DOI":"10.7326\/0003-4819-136-4-200202190-00006","article-title":"Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes: a longitudinal study of the general population","volume":"136","author":"Dahl","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ebiom.2022.104262_bib0006","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/gepi.1370090504","article-title":"Family study of alpha 1-antitrypsin deficiency: effects of cigarette smoking, measured genotype, and their interaction on pulmonary function and biochemical traits","volume":"9","author":"Silverman","year":"1992","journal-title":"Genet Epidemiol"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104262_bib0007","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1164\/rccm.202106-1404OC","article-title":"Alpha-1 Antitrypsin MZ heterozygosity is an endotype of chronic obstructive pulmonary disease","volume":"205","author":"Ghosh","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104262_bib0008","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.chest.2021.01.004","article-title":"Protein biomarkers for COPD outcomes","volume":"159","author":"Serban","year":"2021","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104262_bib0009","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12931-017-0597-7","article-title":"Multiple biomarkers predict disease severity, progression and mortality in COPD","volume":"18","author":"Zemans","year":"2017","journal-title":"Respir Res"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104262_bib0010","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12931-021-01686-z","article-title":"Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD","volume":"22","author":"Pratte","year":"2021","journal-title":"Respir Res"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104262_bib0011","first-page":"204","article-title":"Serum proteins associated with emphysema progression in severe Alpha-1 Antitrypsin deficiency","volume":"4","author":"Beiko","year":"2017","journal-title":"Chronic Obstr Pulm Dis"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104262_bib0012","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1164\/rccm.201901-0010OC","article-title":"The biological effects of double-dose Alpha-1 Antitrypsin augmentation therapy. A pilot clinical trial","volume":"200","author":"Campos","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104262_bib0013","doi-asserted-by":"crossref","first-page":"8382","DOI":"10.1038\/s41598-018-26640-w","article-title":"Stability and reproducibility of proteomic profiles measured with an aptamer-based platform","volume":"8","author":"Kim","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104262_bib0014","doi-asserted-by":"crossref","first-page":"14248","DOI":"10.1038\/s41598-017-14755-5","article-title":"Assessment of variability in the SOMAscan assay","volume":"7","author":"Candia","year":"2017","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.ebiom.2022.104262_bib0015","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201900278","article-title":"Comparison of proteomic assessment methods in multiple cohort studies","volume":"20","author":"Raffield","year":"2020","journal-title":"Proteomics"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104262_bib0016","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3109\/15412550903499522","article-title":"Genetic epidemiology of COPD (COPDGene) study design","volume":"7","author":"Regan","year":"2010","journal-title":"COPD"},{"issue":"10","key":"10.1016\/j.ebiom.2022.104262_bib0017","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1513\/AnnalsATS.201503-143OC","article-title":"Rationale and design of the genomic research in Alpha-1 Antitrypsin deficiency and Sarcoidosis study. Alpha-1 protocol","volume":"12","author":"Strange","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.ebiom.2022.104262_bib0018","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12931-014-0089-y","article-title":"Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene","volume":"15","author":"Wan","year":"2014","journal-title":"Respir Res"},{"key":"10.1016\/j.ebiom.2022.104262_bib0019","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1465-9921-10-75","article-title":"Exploring the optimum approach to the use of CT densitometry in a randomised placebo-controlled study of augmentation therapy in alpha 1-antitrypsin deficiency","volume":"10","author":"Parr","year":"2009","journal-title":"Respir Res"},{"issue":"8","key":"10.1016\/j.ebiom.2022.104262_bib0020","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1513\/AnnalsATS.201611-838OC","article-title":"Alpha-1 Antitrypsin PiMZ genotype is associated with chronic obstructive pulmonary disease in two racial groups","volume":"14","author":"Foreman","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.ebiom.2022.104262_bib0021","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1471-2105-10-48","article-title":"GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists","volume":"10","author":"Eden","year":"2009","journal-title":"BMC Bioinf"},{"issue":"1-2","key":"10.1016\/j.ebiom.2022.104262_bib0022","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0166-4328(01)00297-2","article-title":"Controlling the false discovery rate in behavior genetics research","volume":"125","author":"Benjamini","year":"2001","journal-title":"Behav Brain Res"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104262_bib0023","first-page":"592","article-title":"Single-Inhaler triple versus dual therapy in patients with COPD","volume":"379","author":"Lipson","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2022.104262_bib0024","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2466-7-10","article-title":"Design of the endobronchial Valve for Emphysema Palliation Trial (VENT): a non-surgical method of lung volume reduction","volume":"7","author":"Strange","year":"2007","journal-title":"BMC Pulm Med"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104262_bib0025","doi-asserted-by":"crossref","DOI":"10.3390\/metabo10040124","article-title":"Identifying protein-metabolite networks associated with COPD phenotypes","volume":"10","author":"Mastej","year":"2020","journal-title":"Metabolites"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104262_bib0026","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s41591-019-0415-5","article-title":"A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes","volume":"25","author":"Niewczas","year":"2019","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104262_bib0027","doi-asserted-by":"crossref","first-page":"19202","DOI":"10.1038\/s41598-019-55727-1","article-title":"Circulating proteomic signature of early death in heart failure patients with reduced ejection fraction","volume":"9","author":"Cuvelliez","year":"2019","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104262_bib0028","doi-asserted-by":"crossref","first-page":"e12799","DOI":"10.1111\/acel.12799","article-title":"Plasma proteomic signature of age in healthy humans","volume":"17","author":"Tanaka","year":"2018","journal-title":"Aging Cell"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104262_bib0029","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000208521","article-title":"Decreased expression of p12 is associated with more advanced tumor invasion in human gastric cancer tissues","volume":"42","author":"Choi","year":"2009","journal-title":"Eur Surg Res"},{"issue":"10","key":"10.1016\/j.ebiom.2022.104262_bib0030","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1158\/1078-0432.CCR-04-2085","article-title":"p12CDK2-AP1 gene therapy strategy inhibits tumor growth in an in vivo mouse model of head and neck cancer","volume":"11","author":"Figueiredo","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104262_bib0031","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/pros.21249","article-title":"Cell-cycle regulators cdk2ap1 and bicalutamide suppress malignant biological interactions between prostate cancer and bone cells","volume":"71","author":"Zolochevska","year":"2011","journal-title":"Prostate"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104262_bib0032","doi-asserted-by":"crossref","first-page":"e4518","DOI":"10.1371\/journal.pone.0004518","article-title":"Targeted inactivation of p12, CDK2 associating protein 1, leads to early embryonic lethality","volume":"4","author":"Kim","year":"2009","journal-title":"PLoS One"},{"issue":"5 suppl","key":"10.1016\/j.ebiom.2022.104262_bib0033","doi-asserted-by":"crossref","first-page":"166S","DOI":"10.1378\/chest.121.5_suppl.166S","article-title":"Mucin apoprotein expression in COPD","volume":"121","author":"Leikauf","year":"2002","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104262_bib0034","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1183\/09031936.00146413","article-title":"Targeting EGFR signalling in chronic lung disease: therapeutic challenges and opportunities","volume":"44","author":"Vallath","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ebiom.2022.104262_bib0035","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.3389\/fgene.2019.01154","article-title":"The gene expression biomarkers for chronic obstructive pulmonary disease and interstitial lung disease","volume":"10","author":"Yao","year":"2019","journal-title":"Front Genet"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104262_bib0036","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1309\/W1AXKGT7UA37X257","article-title":"Expression of epidermal growth factors and their receptors in the bronchial epithelium of subjects with chronic obstructive pulmonary disease","volume":"125","author":"de Boer","year":"2006","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104262_bib0037","first-page":"668","article-title":"The diagnosis and management of Alpha-1 Antitrypsin deficiency in the adult","volume":"3","author":"Sandhaus","year":"2016","journal-title":"Chronic Obstr Pulm Dis"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104262_bib0038","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02410-2019","article-title":"Clinical considerations in individuals with alpha1-antitrypsin Pi*SZ genotype","volume":"55","author":"McElvaney","year":"2020","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104262_bib0039","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1164\/rccm.201311-1984OC","article-title":"Clarification of the risk of chronic obstructive pulmonary disease in alpha1-antitrypsin deficiency PiMZ heterozygotes","volume":"189","author":"Molloy","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104262_bib0040","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00408-018-0163-1","article-title":"Free desmosine is a sensitive marker of smoke-induced emphysema","volume":"196","author":"Cantor","year":"2018","journal-title":"Lung"},{"key":"10.1016\/j.ebiom.2022.104262_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2019.105814","article-title":"End-product of fibrinogen is elevated in emphysematous chronic obstructive pulmonary disease and is predictive of mortality in the ECLIPSE cohort","volume":"160","author":"Manon-Jensen","year":"2019","journal-title":"Respir Med"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104262_bib0042","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1164\/rccm.201410-1771OC","article-title":"Plasma sphingolipids associated with chronic obstructive pulmonary disease phenotypes","volume":"191","author":"Bowler","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104262_bib0043","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1183\/13993003.01824-2015","article-title":"Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPD","volume":"47","author":"Rabinovich","year":"2016","journal-title":"Eur Respir J"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422004443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422004443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:20:26Z","timestamp":1762456826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396422004443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":43,"alternative-id":["S2352396422004443"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.104262","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unique and shared systemic biomarkers for emphysema in Alpha-1 Antitrypsin deficiency and chronic obstructive pulmonary disease","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.104262","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104262"}}